Photo: Tetra Images/Getty Images
Successful AI adoption in healthcare requires intentional strategy rather than experimentation, according to Dr. Bill Fera, genAI leader for life sciences and healthcare at Deloitte Consulting.
"There is absolutely a tension between wanting to protect intellectual property and wanting to provide that openness. I don't think we've figured out how to solve for that tension yet, but we still have to keep pushing on it," Fera said.
To learn more about Deloitte's view on the necessity of AI guardrails, listen to the full conversation between Dr. Fera and Jessica Hagen, executive editor of MobiHealthNews.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Amazon Music.
Talking points:
- AI's effect on the healthcare workforce
- Establishing frameworks for accountability
- AI transparency
- Validating AI results with clinicians
- Promising technologies risk limited adoption
More about this episode:
Q&A: Deloitte on AI transparency and the future of computer vision in healthcare
Executive predictions for healthcare AI in 2026, Part 2
Q&A: AWS on new AI agents, quantum computing in healthcare
Executives discuss AI reshaping the healthcare workforce, Part 1
Q&A: Former U.S. chief technology officer Aneesh Chopra on AI in healthcare
Email the writer: jhagen@himm.org
